Table 3:

Recommendations from the Common Drug Review and pan-Canadian Oncology Drug Review

No. of drugs that received a recommendation; classificationNo. of drugs that did not receive a recommendation; reason
List in formulary in a manner similar to other drugs in the same classList subject to conditionsDo not list*Approved before start of CDR or pCODROther
  • Note: CDR = Common Drug Review, pCODR = pan-Canadian Oncology Drug Review.

  • * For 1 of these drugs, the recommendation was that the drug not be listed at the price submitted by the company.

  • Reason not available.